机构:[1]Department of Molecular Biology, The Fourth Affiliated Hospital of Hebei Medical University, Hebei Province, China医技科室分子生物学室河北医科大学第四医院[2]Divison of Cancer Prevention and Control, The Fourth Affiliated Hospital of Hebei Medical University, Hebei Province, China河北医科大学第四医院
Background and Aim: The FAS and FASL system play an important role in regulating apoptotic cell death. This study was designed to investigate the correlation of FAS-1377 G/A, -670 A/G and FASL-844 T/C polymorphisms with susceptibility to gastric cardiac adenocarcinoma in a population of a high-incidence region of Hebei Province. Methods: FAS-1377 G/A, -670 A/G and FASL-844 T/C polymorphisms were genotyped by polymerase chain reaction-restriction fragment length polymorphism analysis in 262 gastric cardiac carcinoma (GCA) patients and 524 healthy controls. Results: Family history of upper gastrointestinal cancer (UGIC) might increase the risk of developing GCA (age- and sex-adjusted odds ratio [OR] = 1.38, 95% confidence interval [CI] = 1.02-1.86). The overall allelotype and genotype distributions of FAS-1377 G/A, and FASL-844 T/C polymorphisms in GCA patients did not significantly differ from that in healthy controls (P > 0.05). Compared with individuals with a FAS-670 A/A genotype, individuals with an A/G genotype in a smoker group had a lower risk of developing GCA (age, sex, and family history of UGIC adjusted OR = 0.55, 95% CI = 0.34-0.88). When the genotypes of FAS and FASL single nucleotide polymorphisms (SNP) were combined to analyze, no significant correlation was found between these SNP and the risk for GCA development. Conclusion: In the high-incidence region of Hebei Province, FAS-1377 G/A and FASL-844 T/C polymorphisms were not associated with the risk of GCA. However, the FAS-670 A/G genotype might decrease the risk of GCA for smoker individuals.
基金:
This work was supported by funds for the Construction of Potentially
Distinguished Scientific Projects in the program of Hebei
Universities.
第一作者机构:[1]Department of Molecular Biology, The Fourth Affiliated Hospital of Hebei Medical University, Hebei Province, China
通讯作者:
通讯机构:[1]Department of Molecular Biology, The Fourth Affiliated Hospital of Hebei Medical University, Hebei Province, China[*1]12 Jiankang Road, Shijiazhuang, 050011, Hebei Province, China
推荐引用方式(GB/T 7714):
Zhou Rong-Miao,Wang Na,Chen Zhi-Feng,et al.Polymorphisms in promoter region of FAS and FASL gene and risk of gastric cardiac adenocarcinoma[J].JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY.2010,25(3):555-561.doi:10.1111/j.1440-1746.2009.06116.x.
APA:
Zhou, Rong-Miao,Wang, Na,Chen, Zhi-Feng,Duan, Ya-Nan,Sun, Dong-Lan&Li, Yan.(2010).Polymorphisms in promoter region of FAS and FASL gene and risk of gastric cardiac adenocarcinoma.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,25,(3)
MLA:
Zhou, Rong-Miao,et al."Polymorphisms in promoter region of FAS and FASL gene and risk of gastric cardiac adenocarcinoma".JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 25..3(2010):555-561